Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells called a plasma cell. Cancer is called relapsed if it comes back after treatment and is called 'refractory' if does not respond to treatment) who have received at least 3 prior lines of therapy.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| O Neal Comprehensive Cancer Center at UAB | Birmingham, Alabama, United States | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| City of Hope | Duarte, California, United States | Recruiting |
| City of Hope Orange County Lennar Foundation Cancer Center | Irvine, California, United States | Recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Rocky Mountain Cancer Centers | Aurora, Colorado, United States | Recruiting |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | Recruiting |
| Cancer Specialists of North Florida | Jacksonville, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Northside Hospital Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| Cancer Care Specialists of Central Illinois | O'Fallon, Illinois, United States | Recruiting |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07266441